A conservative buyer guide to plasma proteomic cell-type aging research, what it could mean for longevity clinics, and why it is not yet a diagnostic or treatment engine.
A buyer-focused guide to epigenetic testing at longevity clinics: when biological-age clocks add useful context, when they become sales theater, and what to ask before paying.
A buyer guide to the AI health coach longevity clinic stack: biomarker dashboards, wearables, clinician review, privacy, export rights, and follow-up thresholds.
A practical 2026 guide to biological age testing in longevity clinics: epigenetic clocks, proteomic and multi-omics clocks, imaging-derived organ age, inflammatory markers, and the clinical tests that actually change decisions.